Click amount to donate direct to CounterPunch
  • $25
  • $50
  • $100
  • $500
  • $other
  • use PayPal
Keep CounterPunch ad free. Support our annual fund drive today!

The Komen Con


Nancy Goodman Brinker, a pioneer of “cause marketing”, founded Susan G. Komen For the Cure in 1982, reportedly as the fulfillment of a deathbed promise made to her sister, a victim of breast cancer. In 1994, Brinker founded In Your Corner, Inc., a for-profit company that markets health products and information. In 1998, Brinker sold In Your Corner to AstraZeneca, the third largest pesticide manufacturer in the world, primarily through Syngenta, a giant global agribusiness company it owns jointly with Novartis.

AstraZeneca has had close ties to Brinker for many years. It gave $97,000 to Komen and its affiliates in the first 6 months of 2008 alone, and it has been a big presence at Komen’s Race for the Cure. AstraZeneca is also one of the largest contributors to Breast Cancer Awareness Month.

The problem here is that pesticides cause breast cancer.

AstraZeneca solves the problem by no longer advertising itself as a pesticide manufacturer.  It is a “life-sciences” company. Ta da! Problem solved! Well, they still manufacture more pesticides than ever (substances that congregate in the sexual glands of mammals causing cancers, birth defects, etc., etc.,) but “life sciences” sounds so reassuring, yes?

Susan G. Komen has created a lengthy list of risk factors for breast cancer.  Nowhere in this list can you find exposure to toxins, probably the greatest risk factor of all.

Hey Nancy! Didn’t your sister ask you to cure breast cancer? Was her dying wish, “Please forgive them for killing me, pay yourself half a million dollars a year – and oh by the way please protect those poor pesticide manufacturers. They know not what they do.”

It gets worse. You’ve heard the famous slogan “The best prevention is early detection.” Think about it: If you get breast cancer, you didn’t see the doctor soon enough. Your fault. Next case.

No wonder AstraZeneca gives handsomely. The focus of Komen and pharmaceutical research is entirely on screening and treatment, not on prevention. In other words, “the cure” focuses on the symptoms and ignores the cause. Less than 5% of the total research dollars in this country are spent determining and eliminating the causes of cancer — none of that money, you can bet, spent by “life sciences” companies.

You have to hand it to AstraZeneca. Not only do they recognize and reward good propaganda when they see it, they also recognize a great market opportunity. Since the 90’s, AstraZeneca has bought up cancer treatment centers until it owns one of the country’s largest chains. With $13 billion in profits in 2011, it makes billions on oncology drugs, and it makes billions on pesticides and herbicides.

In business parlance, this is “vertical integration.” AstraZeneca causes cancer, they give money to charities that ignore the causes of cancer, and they “cure” us with their toxic drugs. An enviable business model–the worse the product, the more money they make.

And AstraZeneca isn’t the only culprit in this unholy alliance. General Electric is also a large contributor to Susan G. Komen. Mammograms have come under heavy criticism in recent years for needlessly exposing patients to radiation, and for yielding numerous false positives which often result in unnecessary surgeries. Unlike many doctors and charities, Komen continues to recommend annual mammograms. GE, not so coincidentally, is a huge manufacturer of mammogram equipment. Europe has a only fraction of the breast surgeries that occur in the U.S., and yet they have nearly identical rates of cancer deaths.

It is hard not to think of Komen as a pure propaganda ploy, and a great tool for supplying qualified prospects to the cancer industry. Is it any surprise that Nancy Brinker was a bundler of campaign contributions for George W. Bush and also a Bush Pioneer, a title that required making contributions of at least $100,000 to his Presidential Campaign? Is it surprising that the staff of Komen is stuffed full of right-wing extremists? Anyone surprised by Komen’s decision to drop Planned Parenthood?

If you are surprised, you’ve bought Susan G. Komen’s purported mission of “curing” breast cancer, rather than understanding the real mission of the cancer-industry and its supporters in the “life science” of killing insects with chemicals that also kill humans. Putting the spotlight upon this unholy alliance is making some very rich, very immoral people very nervous.

Expect a rash of corporate name changes and massive increases in public relations budgets if the attention lasts much longer. What one should not expect is any change in business practices.

Douglas A. Berg is a computer scientist and children’s book writer in Mesa, Arizona. He contributed this article to ThisCantBeHappening!, the new independent Project Censored Award-winning online alternative newspaper, which is available at











More articles by:

2016 Fund Drive
Smart. Fierce. Uncompromised. Support CounterPunch Now!

  • cp-store
  • donate paypal

CounterPunch Magazine


October 20, 2016
Eric Draitser
Syria and the Left: Time to Break the Silence
Jeffrey St. Clair
Extreme Unction: Illusions of Democracy in Vegas
Binoy Kampmark
Digital Information Warfare: WikiLeaks, Assange and the US Presidential Elections
Jonathan Cook
Israel’s Bogus History Lesson
Bruce Mastron
Killing the Messenger, Again
Anthony DiMaggio
Lesser Evil Voting and Prospects for a Progressive Third Party
Ramzy Baroud
The Many ‘Truths’ on Syria: How Our Rivalry Has Destroyed a Country
David Rosen
Was Bill Clinton the Most Sexist President?
Laura Carlsen
Plan Colombia, Permanent War and the No Vote
Aidan O'Brien
Mao: Monster or Model?
David Swanson
Barbara Nimri Aziz
Less Than Two Weeks
Victor Grossman
Suicides and Hopes and Fears
October 19, 2016
Dan Schiller – Shinjoung Yeo
The Silicon Valley Candidate
Mike Whitney
Trump Unchained
Paul Buhle
Criminalizing the Struggle: Incarceration and the Rise of the Neoliberal State
Linn Washington Jr.
Abusing the Abused: Philly Police Abuse Case Typifies All-Too-Common Misconduct by US Prosecutors
Terry Tempest Williams - Brooke Williams
Rejected by the BLM
Binoy Kampmark
Neither War Nor Peace: Shimon Peres, Israel and History
Patrick Cockburn
This Battle for Mosul Will Not Be the Last
Joyce Nelson
Trudeau Bullying on Trade Deal
Thomas Mountain
Revolutionary Islam and Regime Change in Ethiopia
Serge Halimi – Benoît Bréville
The Limits of Eloquence: the Failures of Barack Obama
Mel Gurtov
America’s Dangerous Moment
Jerry Kroth
Questions for Obama Before Leaving Office
Michael Garrity
America is a Nation of Laws: Collaboration and Its Discontents
October 18, 2016
Srećko Horvat
The Cyber-War on Wikileaks
Zoltan Grossman
Stop the Next President From Waging the Next War
Jim Kavanagh
Hillary’s Hide-and-Seek
Robert Fisk
After Mosul Falls, ISIS will Flee to Syria. Then What?
Ted Rall
The 4 Things Hillary Could Do To Close the Deal Against Trump
Pepe Escobar
Why Hillary Clinton is a Bigger Concern for China than Donald Trump
Colin Todhunter
World Wide Fund for Nature: Stop Greenwashing Capitalism, Start Holding Corporations to Account
David Macaray
Whiskey Workers Go on Strike: I’ll Drink to That
James A Haught
After the Election, Back to Important Things
Arturo Desimone
How a Selective Boycott Can Boost External Support for Palestinians
Russell Mokhiber
If Chris Wallace Asks About Street Crime He Should Also Ask About Corporate Crime
Mark Kernan
Moloch in Paris: on the Anniversary of COP21
Carol Dansereau
The Hillary Push: Manipulation You Can Believe In
Andre Vltchek
Will They Really Try to Kill the President of the Philippines?
Sean Joseph Clancy
The Wreckage of Matthew: Cuba and Haiti
October 17, 2016
Paul Street
Pick Your Poison? Presidential Politics and Planetary Prospects
Patrick Cockburn
US Allies are Funding ISIS (and Hillary Knew All Along)
David Swanson
What Hillary Clinton Privately Told Goldman Sachs
Fran Shor
A Rigged System?